Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study of LY3502970 in Healthy Overweight and Obese Participants
Sponsor: Eli Lilly and Company
Summary
The main purpose of this study is to evaluate the safety and tolerability of LY3502970 in healthy overweight and obese participants. The blood tests will be conducted to measure how much LY3502970 is in the bloodstream and how the body handles and eliminates LY3502970 in these participants. The study will last up to 42 days excluding the screening period.
Official title: A Multiple Dose Study in Healthy Overweight and Obese Participants to Investigate the Safety, Tolerability, and Pharmacokinetics of LY3502970
Key Details
Gender
All
Age Range
18 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
72
Start Date
2022-05-26
Completion Date
2022-09-09
Last Updated
2026-05-26
Healthy Volunteers
Yes
Interventions
LY3502970
Administered orally.
Locations (3)
Qps-Mra, Llc
Miami, Florida, United States
ICON Early Phase Services Lenexa Center
Lenexa, Kansas, United States
ICON Early Phase Services
San Antonio, Texas, United States